Annual report pursuant to Section 13 and 15(d)

Merger with Private Molecular - Pro Forma Results in Connection with Merger (Detail)

v3.19.1
Merger with Private Molecular - Pro Forma Results in Connection with Merger (Detail)
$ in Thousands
12 Months Ended
Dec. 31, 2017
USD ($)
Business Combinations [Abstract]  
Revenue $ 6,395
Net loss $ (15,599)